Fig. 5From: A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumoursMutation sites and number of cases of RIPK2 in malignant tumours. K203Nfs*36/Q202H was the site with the highest mutation frequencyBack to article page